Outcomes of Percutaneous Coronary Intervention in Hospitalized Patients with Acute Coronary Syndrome and Heart Failure: Insights from the CCC-ACS Registry Observational Study - Report - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Outcomes of Percutaneous Coronary Intervention in Hospitalized Patients with Acute Coronary Syndrome and Heart Failure: Insights from the CCC-ACS Registry Observational Study

  • By

  • Chu Fan

  • Hangyu Yan

  • Kehang Lei

  • Dan Li

  • Shutong Dong

  • Yue Zhang

  • Cecily Patricia Callister

  • Yutong Cheng

  • Zhao Li

  • Zhizhong Li

  • Haiyan Qian

  • Ji Huang

  • December 30, 2025

Share

Outcomes of Percutaneous Coronary Intervention in ACS Patients with Heart Failure

Overview

This study evaluates the impact of percutaneous coronary intervention (PCI) on hospitalized patients with acute coronary syndrome (ACS) and heart failure (HF). Findings indicate that PCI is associated with lower in-hospital mortality rates among this high-risk population.

Background

Acute coronary syndrome is a leading cause of heart failure, representing a significant clinical challenge due to the complexity and urgency of treatment required. Patients with ACS and HF are classified as extremely high-risk, necessitating prompt evaluation and intervention. Understanding the role of PCI in this context is crucial for improving patient outcomes.

Data Highlights

{'PCI_Performed': 'Specify the number or percentage of patients who underwent PCI.'}

Key Findings

{'in_hospital_mortality': 'Include specific statistics or data points.'}

Clinical Implications

Healthcare professionals should prioritize PCI for ACS patients with heart failure to improve survival outcomes. Timely intervention is critical, and adherence to current guidelines can enhance patient management in this high-risk group.

Conclusion

The findings underscore the importance of PCI in improving in-hospital outcomes for patients with ACS and heart failure. Continued research is needed to optimize treatment strategies for this vulnerable population.

Related Resources & Content

  1. BMC Cardiovascular Disorders, 2025 -- In-hospital outcomes of percutaneous coronary intervention in acute coronary syndrome patients with heart failure: a real-world observational study from the CCC-ACS registry
  2. American College of Cardiology, 2025 -- 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes
  3. Clinical Research in Cardiology — Factors Influencing Symptom Relief in Chronic Coronary Syndrome Patients Following Percutaneous Coronary Intervention
  4. Clinical Research in Cardiology — Impact of Coronary No-Reflow on Clinical Outcomes in Acute Myocardial Infarction Patients Undergoing Percutaneous Coronary Intervention with Modern Drug-Eluting Stents and Third-Generation P2Y12 Inhibitors
  5. European Journal of Preventive Cardiology — Socio-geographical factors associated with cardiac rehabilitation participation after percutaneous coronary intervention: a registry-based cohort study from France
  6. Clinical Research in Cardiology — Comparison of Optical Coherence Tomography and Angiography for Guiding Percutaneous Coronary Intervention in Acute Coronary Syndrome: A Meta-Analysis
  7. 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes - American College of Cardiology
  8. ExtraCorporeal Life Support for acute myocardial infarction complicated by cardiogenic shock - American College of Cardiology
  9. In-hospital outcomes of percutaneous coronary intervention in acute coronary syndrome patients with heart failure: a real-world observational study from the CCC-ACS registry | BMC Cardiovascular Disorders | Springer Nature Link

Original Source(s)

Outcomes of Percutaneous Coronary Intervention in Hospitalized Patients with Acute Coronary Syndrome and Heart Failure: Insights from the CCC-ACS Registry Observational Study

  • by Chu Fan, Hangyu Yan, Kehang Lei, Dan Li, Shutong Dong, Yue Zhang, Cecily Patricia Callister, Yutong Cheng, Zhao Li, Zhizhong Li, Haiyan Qian, Ji Huang

  • December 30, 2025

Related Content

Disparities in the management of cardiogenic shock complicating acute myocardial infarction: a questionnaire survey in Beijing

FDA updates PAH label with trial data

In adults diagnosed with pulmonary arterial hypertension within the previous year, adding sotatercept to background therapy reduced the risk of clinical worsening events by 76% compared with placebo.

Influence of left ventricular ejection fraction on the clinical outcome of percutaneous coronary interventions in heart transplant patients